Turner MedTech, a certified medical device contract manufacturer, has signed a Memorandum of Understanding (MOU) with PollenSense to manufacture its advanced pollen detection device. The partnership aims to bring a cutting-edge technology to market that provides real-time pollen monitoring for individuals with allergies.
The PollenSense device utilizes sophisticated sensor technology to deliver hyperlocal pollen and mold count information, representing a significant improvement over traditional manual monitoring methods. By offering precise, location-specific data, the device could help allergy sufferers better manage their symptoms and improve their overall quality of life.
Charles Jensen, VP/GM of Turner MedTech, expressed confidence in the company's manufacturing capabilities, stating they are prepared to produce the PollenSense device to the highest quality standards. The partnership is expected to create new employment opportunities and contribute to economic growth in Utah.
Production is scheduled to commence in the second quarter of 2025, with the potential to provide valuable environmental health information to millions of individuals affected by pollen-related allergies. The collaboration highlights the ongoing innovation in medical device technology and personalized health monitoring solutions.
